Oriol Mirallas

17PUBLICATIONS
149CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 30, 2026
"SMAC"-down for the apoptosis-restoring drug, Xevinapant: What does its story reveal?

|Jun 09, 2026
Educational needs in neuro-oncology: Insights from the European Society for Medical Oncology Central Nervous System Faculty Survey.

|Jan 06, 2026
Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study.

Oriol Mirallas, Fiorella Ruiz-Pace, Gabriel Velilla

|Dec 21, 2025
Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response.

Daniel Navarro-Garcia, Francesco Grussu, Christina Zatse

|Dec 16, 2025
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.

Elena Garralda, Charles Abbott, Alma Calahorro

|Nov 28, 2025
Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysis.

Pablo Jimenez-Labaig, Oriol Mirallas, Ana Isabel Martin-Quesada

Pageof 3

Frequent Collaborators

4 joint publications

Joan Brunet

3 joint publications

Irene Braña

2 joint publications

Mark Bower

2 joint publications

Nadia Harbeck